GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Book Value per Share

Square Pharmaceuticals (DHA:SQURPHARMA) Book Value per Share : BDT151.94 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Book Value per Share?

Square Pharmaceuticals's book value per share for the quarter that ended in Mar. 2025 was BDT151.94.

During the past 12 months, Square Pharmaceuticals's average Book Value Per Share Growth Rate was 10.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 10.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Square Pharmaceuticals was 22.80% per year. The lowest was -44.20% per year. And the median was 17.00% per year.

Square Pharmaceuticals's current price is BDT208.70. Its book value per share for the quarter that ended in Mar. 2025 was BDT151.94. Hence, today's PB Ratio of Square Pharmaceuticals is 1.37.

During the past 13 years, the highest P/B Ratio of Square Pharmaceuticals was 4.83. The lowest was 1.37. And the median was 2.21.

Good Sign:

Square Pharmaceuticals PLC stock PB Ratio (=1.37) is close to 10-year low of 1.37.


Square Pharmaceuticals Book Value per Share Historical Data

The historical data trend for Square Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Book Value per Share Chart

Square Pharmaceuticals Annual Data
Trend Mar15 Mar16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.21 104.53 118.68 129.95 142.05

Square Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.39 142.05 149.76 145.52 151.94

Competitive Comparison of Square Pharmaceuticals's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Square Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Square Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Square Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Square Pharmaceuticals's PB Ratio falls into.


;
;

Square Pharmaceuticals Book Value per Share Calculation

Square Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Jun. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(125,919-0)/886
=142.05

Square Pharmaceuticals's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(134,686-0)/886
=151.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Square Pharmaceuticals  (DHA:SQURPHARMA) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Square Pharmaceuticals Book Value per Share Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Square Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs for health care for all living species. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. Company also provides devices such as AnsuPen and AnsuPen Twist. The company operates in Bangladesh and sells its products locally and internationally.

Square Pharmaceuticals Headlines

No Headlines